VCTX211 Combination Product
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VCTX211 Combination Product, covering 2024-05-23 to 2024-05-23. Get the full timeline:
Most recent: Clinical Trial Update: An Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects With T1D [Phase 1, Phase 2]